Volume 9 - Issue 9 - September 2012
09/06/2012
Q: Tell me about your motivations in using the new Endurant II AAA Stent Graft.A: My patient was a 70-year-old gentleman with two issues that made him an excellent candidate to consider for aortic endografting. The first was that he had a...
Q: Tell me about your motivations in using the new Endurant II AAA Stent Graft.A: My patient was a 70-year-old gentleman with two issues that made him an excellent candidate to consider for aortic endografting. The first was that he had a...
Q: Tell me about your...
09/06/2012
Vascular Disease Management
Insights
Interview
09/06/2012
My patient was a 70-year-old gentleman with two issues that made him an excellent candidate to consider for aortic endografting. The first was that he had a hostile abdomen secondary to a previous Whipple procedure and multiple subsequent...
My patient was a 70-year-old gentleman with two issues that made him an excellent candidate to consider for aortic endografting. The first was that he had a hostile abdomen secondary to a previous Whipple procedure and multiple subsequent...
My patient was a 70-year-old...
09/06/2012
Vascular Disease Management
Feature
Case Report
09/06/2012
In this manuscript, we review the indications and techniques for tibial endovascular intervention and present a 79-year-old male patient with a right great toe ulcer that had been present for 6 weeks. Alternatives for intervention and...
In this manuscript, we review the indications and techniques for tibial endovascular intervention and present a 79-year-old male patient with a right great toe ulcer that had been present for 6 weeks. Alternatives for intervention and...
In this manuscript, we review...
09/06/2012
Vascular Disease Management
Case Report
09/06/2012
PCI is rarely performed in the pediatric population for obstructive coronary disease occurring secondary to non-atherosclerotic conditions. We report two cases of children treated with PCI utilizing radial access.
PCI is rarely performed in the pediatric population for obstructive coronary disease occurring secondary to non-atherosclerotic conditions. We report two cases of children treated with PCI utilizing radial access.
PCI is rarely performed in the...
09/06/2012
Vascular Disease Management
Case Report
09/05/2012
We report a case of adventitial cystic disease of the right popliteal artery in a 43-year-old female patient admitted with complaints of her right foot “falling asleep,” claudication, and cool toes for 6 days.
We report a case of adventitial cystic disease of the right popliteal artery in a 43-year-old female patient admitted with complaints of her right foot “falling asleep,” claudication, and cool toes for 6 days.
We report a case of adventitial...
09/05/2012
Vascular Disease Management
Original Research
09/05/2012
The aim of this study was to evaluate the impact of endovascular treatment for chronic cerebrospinal venous insufficiency on chronic fatigue in multiple sclerosis patients.
The aim of this study was to evaluate the impact of endovascular treatment for chronic cerebrospinal venous insufficiency on chronic fatigue in multiple sclerosis patients.
The aim of this study was to...
09/05/2012
Vascular Disease Management
Case Report
09/05/2012
Aorto-ostial lesions are typically some of the most difficult to treat because of the unique challenges they pose such as difficulty in visualizing the ostium; geometric mismatch of a cylindrical stent being placed into a funnel-shaped...
Aorto-ostial lesions are typically some of the most difficult to treat because of the unique challenges they pose such as difficulty in visualizing the ostium; geometric mismatch of a cylindrical stent being placed into a funnel-shaped...
Aorto-ostial lesions are...
09/05/2012
Vascular Disease Management
Column
Clinical Editor's Corner
09/05/2012
Crux Biomedical’s new inferior vena cava filter received 510(k) FDA clearance for U.S. commercialization last month. The device’s novel helical shape was designed to self-center and to conform more closely to the shape of the vena cava, as...
Crux Biomedical’s new inferior vena cava filter received 510(k) FDA clearance for U.S. commercialization last month. The device’s novel helical shape was designed to self-center and to conform more closely to the shape of the vena cava, as...
Crux Biomedical’s new inferior...
09/05/2012
Vascular Disease Management
